For laboratory research use only. Not for human consumption.

Free U.S. shipping on $200+

Nootropic Research

Selank

Tuftsin-derived peptide & neurotransmission research

$30.00USD / vialView COA

A pair saves 10%. A set of three saves 15%.

Strength 5 MG
Vial quantity
  • Complimentary priority shipping from $200
  • Dispatched within 1–2 business days
  • Compare strengths and prices before ordering

For laboratory research use only.
Not for human consumption or clinical use.

Compound details
Compound
Selank
CAS number
129954-34-3
Molecular formula
C33H57N11O9
Molecular weight
751.87 g/mol
Form
Lyophilized
Quality & documentation

The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.

Lot
GLZ-26-SELANK-1051
HPLC purity
99.719%
Measured content
5.04 mg
Tested
25 Sep 2026
Report
NS-2026-06052
View the 5 MG certificate
Our quality approach
Shipping & handling

Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.

Shipping information
Explore the research profile
Selank5 MG · Single
$30.00

01 / The compound

Understand
the starting point.

Tuftsin-derived peptide & neurotransmission research

Selank is a synthetic heptapeptide composed of seven amino acids with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). It was developed as an analog of tuftsin, a naturally occurring regulatory peptide, by extending the tuftsin sequence with Pro-Gly-Pro.

Selank has been investigated in laboratory research involving neurotransmission, neuropeptide metabolism and BDNF-related signaling.

02 / Research profile

The pathways.
The possibilities.

Mechanistic investigations consider GABA-associated gene expression, enkephalin metabolism and BDNF-related pathways. The observations arise from distinct biochemical and preclinical models, without establishing one universal mechanism.

01 / Research focus

Neurotransmission & GABAergic Research

Selank has been investigated in laboratory models involving GABAergic neurotransmission and gene expression. Published research has examined changes in genes associated with GABA-receptor signaling, including experiments using neuronal cell models and animal systems. These findings provide mechanistic context for studying Selank's relationship with neurotransmission pathways without extending the results beyond the experimental models tested.

02 / Research focus

Enkephalin Metabolism

Laboratory research has examined Selank in relation to enzymes involved in the degradation of enkephalins, a group of endogenous regulatory peptides. In vitro experiments using human serum reported dose-dependent inhibition of enkephalin-degrading enzyme activity by Selank. These findings represent biochemical laboratory research and should be interpreted within the specific in-vitro conditions used.

03 / Research focus

BDNF-Related Research

Selank has also been investigated in animal models examining brain-derived neurotrophic factor, or BDNF. Published rat research has evaluated changes in hippocampal BDNF expression following experimental Selank administration. These findings establish BDNF-related signaling as an area of Selank research and should be interpreted within the specific preclinical model and experimental conditions used.

Reading the evidence

Published Selank research includes cell-based experiments, biochemical studies and animal models examining neurotransmission, GABAergic signaling, neuropeptide metabolism and BDNF-related pathways. Evidence from these different experimental systems should be interpreted according to the specific model, methodology and conditions used in each study. Findings from one experimental system should not automatically be generalized to another.

03 / Reference data

The details,
in plain sight.

Reference specifications describe a compound. The final lot documentation identifies the material supplied.

Selank reference specifications
CompoundSelank
Research areaNootropic Research
CAS number129954-34-3
Molecular formulaC33H57N11O9
Molecular weight751.87 g/mol
Physical formLyophilized
Vial options5 MG · 10 MG
Intended useLaboratory research only

Variant amounts are nominal catalog quantities. They are not instructions for use.

04 / Quality & documentation

A number needs
its context.

How testing works
01 / Purity

What is in the sample?

HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.

02 / Identity

Is it the expected compound?

Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.

03 / Traceability

Does the report match the vial?

Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.

Independent analysis

Every Selank lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.

Read a COA with confidence
Selank lot certificates
PresentationLotHPLC purityTestedCertificate
5 MG Current lotGLZ-26-SELANK-105199.719%25 Sep 2026NS-2026-06052
10 MG Current lotGLZ-26-SELANK-105299.757%14 Sep 2026NS-2026-06053

05 / Storage & handling

Care for
the material.

Keep sealed research material protected from moisture, unnecessary light and temperature fluctuations. Use the storage conditions documented for the specific compound, formulation and lot.

Solution stability depends on solvent, concentration, container and experimental conditions. Use a validated laboratory protocol; a universal post-reconstitution shelf life is not established by the literature summaries.

Explore the handling guide

06 / Common questions

A little more
understanding.

How is Selank related to tuftsin?

Selank extends the tuftsin sequence Thr-Lys-Pro-Arg with Pro-Gly-Pro to form the heptapeptide TKPRPGP. The added residues distinguish the synthetic analogue from its parent peptide.

What kinds of models are represented?

The cited work includes biochemical experiments on enkephalin-degrading enzyme activity, neuronal and animal systems examining GABA-related pathways, and rat studies measuring hippocampal BDNF expression.

07 / Further reading

Go to
the source.

Selected literature for context. Read each study’s methods, experimental model, and limitations alongside its findings.

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05
    Compound Reference: Selank (PubChem CID 11765600). pubchem.ncbi.nlm.nih.gov / Published literature
Our approach to research content

Curated pairings

Often studied together.

Explore the collection

Your research collection

Your bag 0

A new perspective awaits

Your bag is empty.

Explore the collection and find the compounds for your next research question.

Explore compounds

Find a research compound

Try GLP-3-RT, BPC-157, or NAD+.